(FIVN) Five9 - Overview
Stock: Cloud Platform, Virtual Agent, Agent Assist, Workflow Automation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 56.8% |
| Relative Tail Risk | -8.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.53 |
| Alpha | -84.90 |
| Character TTM | |
|---|---|
| Beta | 1.792 |
| Beta Downside | 1.784 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.79% |
| CAGR/Max DD | -0.49 |
Description: FIVN Five9 January 14, 2026
Five9, Inc. (NASDAQ:FIVN) delivers an intelligent, cloud-based customer-experience (CX) platform that unifies voice, chat, email, web, social and mobile channels. Its suite includes AI-driven virtual agents, agent-assist tools, workflow automation, workforce-engagement management, and real-time data integration with enterprise systems such as CRM, enabling firms to route interactions efficiently and boost agent productivity.
In FY 2023 the company reported $1.06 billion in revenue, representing a 21 % year-over-year increase, with non-GAAP operating margin expanding to 14 % and annual recurring revenue (ARR) surpassing $2.1 billion. Customer churn remained low at roughly 4 % on a contract-value basis, indicating strong stickiness in a market where average contract sizes are trending upward (≈ $250 k per customer). These metrics suggest Five9 is capturing a meaningful share of the growing cloud-contact-center spend.
The primary macro drivers for Five9 are the broader shift from on-premise to SaaS contact-center solutions (the cloud-contact-center market is projected to grow at a CAGR of ~13 % through 2028) and accelerating adoption of generative AI to reduce labor costs and improve service quality. Additionally, tighter labor markets in the U.S. and Europe increase demand for automation tools that can augment human agents, while regulatory pressure in banking and healthcare pushes firms toward integrated, audit-ready CX platforms.
For a deeper, data-driven view of Five9’s valuation relative to its peers, you may find it useful to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 31.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.24 > 1.0 |
| NWC/Revenue: 58.40% < 20% (prev 55.27%; Δ 3.13% < -1%) |
| CFO/TA 0.11 > 3% & CFO 192.5m > Net Income 31.3m |
| Net Debt (604.6m) to EBITDA (104.6m): 5.78 < 3 |
| Current Ratio: 4.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.3m) vs 12m ago 16.59% < -2% |
| Gross Margin: 54.99% > 18% (prev 0.53%; Δ 5446 % > 0.5%) |
| Asset Turnover: 59.71% > 50% (prev 49.92%; Δ 9.79% > 0%) |
| Interest Coverage Ratio: 2.62 > 6 (EBITDA TTM 104.6m / Interest Expense TTM 15.3m) |
Altman Z'' 1.43
| A: 0.37 (Total Current Assets 864.2m - Total Current Liabilities 205.7m) / Total Assets 1.77b |
| B: -0.23 (Retained Earnings -397.9m / Total Assets 1.77b) |
| C: 0.02 (EBIT TTM 40.1m / Avg Total Assets 1.89b) |
| D: -0.40 (Book Value of Equity -397.1m / Total Liabilities 993.1m) |
| Altman-Z'' Score: 1.43 = BB |
Beneish M -2.86
| DSRI: 1.03 (Receivables 141.7m/122.9m, Revenue 1.13b/1.00b) |
| GMI: 0.97 (GM 54.99% / 53.37%) |
| AQI: 1.29 (AQ_t 0.39 / AQ_t-1 0.30) |
| SGI: 1.12 (Revenue 1.13b / 1.00b) |
| TATA: -0.09 (NI 31.3m - CFO 192.5m) / TA 1.77b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of FIVN shares?
Over the past week, the price has changed by -3.28%, over one month by -13.48%, over three months by -20.71% and over the past year by -59.30%.
Is FIVN a buy, sell or hold?
- StrongBuy: 12
- Buy: 6
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FIVN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.4 | 95.7% |
| Analysts Target Price | 33.4 | 95.7% |
| ValueRay Target Price | 9.2 | -46.1% |
FIVN Fundamental Data Overview February 03, 2026
P/E Forward = 5.534
P/S = 1.2251
P/B = 1.7822
P/EG = 0.6156
Revenue TTM = 1.13b USD
EBIT TTM = 40.1m USD
EBITDA TTM = 104.6m USD
Long Term Debt = 734.6m USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 798.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 604.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.50b USD (1.38b + Debt 798.0m - CCE 676.2m)
Interest Coverage Ratio = 2.62 (Ebit TTM 40.1m / Interest Expense TTM 15.3m)
EV/FCF = 10.92x (Enterprise Value 1.50b / FCF TTM 137.7m)
FCF Yield = 9.16% (FCF TTM 137.7m / Enterprise Value 1.50b)
FCF Margin = 12.21% (FCF TTM 137.7m / Revenue TTM 1.13b)
Net Margin = 2.77% (Net Income TTM 31.3m / Revenue TTM 1.13b)
Gross Margin = 54.99% ((Revenue TTM 1.13b - Cost of Revenue TTM 507.4m) / Revenue TTM)
Gross Margin QoQ = 54.19% (prev 54.86%)
Tobins Q-Ratio = 0.85 (Enterprise Value 1.50b / Total Assets 1.77b)
Interest Expense / Debt = 0.39% (Interest Expense 3.09m / Debt 798.0m)
Taxrate = 3.45% (643.0k / 18.6m)
NOPAT = 38.7m (EBIT 40.1m * (1 - 3.45%))
Current Ratio = 4.20 (Total Current Assets 864.2m / Total Current Liabilities 205.7m)
Debt / Equity = 1.03 (Debt 798.0m / totalStockholderEquity, last quarter 775.3m)
Debt / EBITDA = 5.78 (Net Debt 604.6m / EBITDA 104.6m)
Debt / FCF = 4.39 (Net Debt 604.6m / FCF TTM 137.7m)
Total Stockholder Equity = 694.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.66% (Net Income 31.3m / Total Assets 1.77b)
RoE = 4.50% (Net Income TTM 31.3m / Total Stockholder Equity 694.8m)
RoCE = 2.81% (EBIT 40.1m / Capital Employed (Equity 694.8m + L.T.Debt 734.6m))
RoIC = 2.36% (NOPAT 38.7m / Invested Capital 1.64b)
WACC = 8.07% (E(1.38b)/V(2.18b) * Re(12.52%) + D(798.0m)/V(2.18b) * Rd(0.39%) * (1-Tc(0.03)))
Discount Rate = 12.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 9.41%
[DCF Debug] Terminal Value 78.79% ; FCFF base≈111.1m ; Y1≈118.8m ; Y5≈143.8m
Fair Price DCF = 23.75 (EV 2.46b - Net Debt 604.6m = Equity 1.86b / Shares 78.2m; r=8.07% [WACC]; 5y FCF grow 7.73% → 2.90% )
EPS Correlation: 3.45 | EPS CAGR: -35.67% | SUE: -3.13 | # QB: 0
Revenue Correlation: 99.05 | Revenue CAGR: 14.22% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.66 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=21
EPS next Year (2026-12-31): EPS=3.18 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+8.1% | Growth Revenue=+9.4%